These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36457256)

  • 1. Lumican modulates adipocyte function in obesity-associated type 2 diabetes.
    Strieder-Barboza C; Flesher CG; Geletka LM; Eichler T; Akinleye O; Ky A; Ehlers AP; Lumeng CN; O'Rourke RW
    Adipocyte; 2022 Dec; 11(1):665-675. PubMed ID: 36457256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-Specific Regulation of Adipocyte Metabolism by the Adipose Tissue Extracellular Matrix.
    Baker NA; Muir LA; Washabaugh AR; Neeley CK; Chen SY; Flesher CG; Vorwald J; Finks JF; Ghaferi AA; Mulholland MW; Varban OA; Lumeng CN; O'Rourke RW
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1032-1043. PubMed ID: 28359093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis.
    Wolff G; Taranko AE; Meln I; Weinmann J; Sijmonsma T; Lerch S; Heide D; Billeter AT; Tews D; Krunic D; Fischer-Posovszky P; Müller-Stich BP; Herzig S; Grimm D; Heikenwälder M; Kao WW; Vegiopoulos A
    Mol Metab; 2019 Jan; 19():97-106. PubMed ID: 30409703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue depot-specific intracellular and extracellular cues contributing to insulin resistance in obese individuals.
    Guzmán-Ruiz R; Tercero-Alcázar C; Rabanal-Ruiz Y; Díaz-Ruiz A; El Bekay R; Rangel-Zuñiga OA; Navarro-Ruiz MC; Molero L; Membrives A; Ruiz-Rabelo JF; Pandit A; López-Miranda J; Tinahones FJ; Malagón MM
    FASEB J; 2020 Jun; 34(6):7520-7539. PubMed ID: 32293066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage?
    Pereira MJ; Vranic M; Kamble PG; Jernow H; Kristófi R; Holbikova E; Skrtic S; Kullberg J; Svensson MK; Hetty S; Eriksson JW
    Transl Res; 2022 Apr; 242():105-121. PubMed ID: 34896253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Gα
    Leiss V; Schönsiegel A; Gnad T; Kerner J; Kaur J; Sartorius T; Machann J; Schick F; Birnbaumer L; Häring HU; Pfeifer A; Nürnberg B
    Mol Metab; 2020 Oct; 40():101029. PubMed ID: 32480042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAM13A and POM121C are candidate genes for fasting insulin: functional follow-up analysis of a genome-wide association study.
    Lundbäck V; Kulyte A; Strawbridge RJ; Ryden M; Arner P; Marcus C; Dahlman I
    Diabetologia; 2018 May; 61(5):1112-1123. PubMed ID: 29487953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rho GTPase RND3 regulates adipocyte lipolysis.
    Dankel SN; Røst TH; Kulyté A; Fandalyuk Z; Skurk T; Hauner H; Sagen JV; Rydén M; Arner P; Mellgren G
    Metabolism; 2019 Dec; 101():153999. PubMed ID: 31672447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte integrin-linked kinase plays a key role in the development of diet-induced adipose insulin resistance in male mice.
    Bugler-Lamb AR; Hasib A; Weng X; Hennayake CK; Lin C; McCrimmon RJ; Stimson RH; Ashford MLJ; Wasserman DH; Kang L
    Mol Metab; 2021 Jul; 49():101197. PubMed ID: 33647469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes.
    Russo L; Muir L; Geletka L; Delproposto J; Baker N; Flesher C; O'Rourke R; Lumeng CN
    Mol Metab; 2020 Sep; 39():100983. PubMed ID: 32229247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-33 inhibits glucose uptake in human adipocytes and its expression in adipose tissue is elevated in insulin resistance and type 2 diabetes.
    Pereira MJ; Azim A; Hetty S; Nandi Jui B; Kullberg J; Lundqvist MH; Eriksson JW
    Cytokine; 2023 Jan; 161():156080. PubMed ID: 36368230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes.
    Ozaki KI; Awazu M; Tamiya M; Iwasaki Y; Harada A; Kugisaki S; Tanimura S; Kohno M
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E643-E651. PubMed ID: 26860984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans.
    Verboven K; Wouters K; Gaens K; Hansen D; Bijnen M; Wetzels S; Stehouwer CD; Goossens GH; Schalkwijk CG; Blaak EE; Jocken JW
    Sci Rep; 2018 Mar; 8(1):4677. PubMed ID: 29549282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting serotonin signaling through HTR2B in visceral adipose tissue improves obesity-related insulin resistance.
    Choi WG; Choi W; Oh TJ; Cha HN; Hwang I; Lee YK; Lee SY; Shin H; Lim A; Ryu D; Suh JM; Park SY; Choi SH; Kim H
    J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34618686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated atrial natriuretic peptide-mediated lipolysis in subcutaneous adipocytes of obese type 2 diabetic men.
    Verboven K; Hansen D; Moro C; Eijnde BO; Hoebers N; Knol J; Bouckaert W; Dams A; Blaak EE; Jocken JW
    Clin Sci (Lond); 2016 Jul; 130(13):1105-14. PubMed ID: 27129190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obesity and diabetes - are they always together?].
    Shestakova MV; Shestakova EA; Sklyanik IA; Stafeev IS
    Ter Arkh; 2022 Nov; 94(10):1131-1135. PubMed ID: 36468985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocyte lipolysis and insulin resistance.
    Morigny P; Houssier M; Mouisel E; Langin D
    Biochimie; 2016 Jun; 125():259-66. PubMed ID: 26542285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocyte-specific deletion of Depdc5 exacerbates insulin resistance and adipose tissue inflammation in mice.
    Zhang J; Shi Y; Yang C; Sun B; Ma H; Huang R; Li Z; Wang M; Wang Q; Ma J; Xiong X
    Biochem Biophys Res Commun; 2021 Sep; 569():118-124. PubMed ID: 34243067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKN1 Kinase: A Key Player in Adipocyte Differentiation and Glucose Metabolism.
    Herrerías-González F; Yeramian A; Baena-Fustegueras JA; Bueno M; Fleitas C; de la Fuente M; Serrano JCE; Granado-Serrano A; Santamaría M; Yeramian N; Zorzano-Martínez M; Mora C; Lecube A
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and β-adrenergic receptors mediate lipolytic and anti-lipolytic signalling that is not altered by type 2 diabetes in human adipocytes.
    Jönsson C; Castor Batista AP; Kjølhede P; Strålfors P
    Biochem J; 2019 Oct; 476(19):2883-2908. PubMed ID: 31519735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.